NCT00000761View on ClinicalTrials.gov

Phase I/II Study of Recombinant Human Interferon-gamma (rIFN-gamma) in HIV-Infected Children

PHASE1CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

Not specified

Study Completion Date

October 31, 1997

Conditions
HIV Infections
Interventions
DRUG

Interferon gamma-1b

Trial Locations (2)

77030

Texas Children's Hosp. CRS, Houston

191044318

The Children's Hosp. of Philadelphia IMPAACT CRS, Philadelphia

Sponsors

Collaborators (1)

Genentech, Inc.
All Listed Sponsors
collaborator

Genentech, Inc.

INDUSTRY

lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH